SCHEMBL26314528

SCHEMBL26314528

Cc1ccc2nccc(Nc3ccc(C(=O)Nc4cccc(Nc5ccncc5)c4)c(C)c3)c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.55
MAPT P10636 2/20 0.55
KMT2A Q03164 2/20 0.55
POLB P06746 2/20 0.55
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
THRB P10828 1/20 0.55
MAPK1 P28482 1/20 0.55
MCL1 Q07820 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
DNMT1 P26358 7/20 0.54
DNMT3A Q9Y6K1 6/20 0.54
DNMT3L Q9UJW3 4/20 0.49
EGFR P00533 3/20 0.48
MAPKAPK2 P49137 1/20 0.44
EHMT1 Q9H9B1 2/20 0.44
MAPK14 Q16539 4/20 0.44
KCNK3 O14649 1/20 0.43
KCNK9 Q9NPC2 1/20 0.43
MAPK9 P45984 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24006111 0.91 DNMT1 (0.66) USP2MAPTKMT2APOLBKDM4E
SCHEMBL24003982 0.91 DNMT1 (0.66) USP2MAPTKMT2APOLBKDM4E
SCHEMBL26314582 0.91 USP2 (0.54) USP2MAPTKMT2APOLBKDM4E
SCHEMBL26332091 0.91 USP2 (0.54) USP2MAPTKMT2APOLBKDM4E
SCHEMBL24003837 0.91 MAPT (0.54) USP2MAPTKMT2APOLBKDM4E
SCHEMBL24003754 0.88 USP2 (0.51) USP2MAPTKMT2APOLBKDM4E
SCHEMBL30290952 0.87 DNMT1 (0.62) USP2MAPTKMT2APOLBKDM4E
SCHEMBL24006421 0.87 DNMT1 (0.62) USP2MAPTKMT2APOLBKDM4E
SCHEMBL24010295 0.87 DNMT1 (0.62) USP2MAPTKMT2APOLBKDM4E
SCHEMBL26314521 0.86 DNMT1 (0.53) USP2MAPTKMT2APOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR USP2 3789/4885MAPT 3962/4885KMT2A 3925/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.